These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 35680060)

  • 21. Preventive effect of sildenafil on right ventricular function in rats with monocrotaline-induced pulmonary arterial hypertension.
    Yoshiyuki R; Tanaka R; Fukushima R; Machida N
    Exp Anim; 2016 Jul; 65(3):215-22. PubMed ID: 26876436
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pioglitazone alleviates cardiac and vascular remodelling and improves survival in monocrotaline induced pulmonary arterial hypertension.
    Behringer A; Trappiel M; Berghausen EM; Ten Freyhaus H; Wellnhofer E; Odenthal M; Blaschke F; Er F; Gassanov N; Rosenkranz S; Baldus S; Kappert K; Caglayan E
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Apr; 389(4):369-79. PubMed ID: 26742933
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chronic inhibition of phosphodiesterase 5 does not prevent pressure-overload-induced right-ventricular remodelling.
    Schäfer S; Ellinghaus P; Janssen W; Kramer F; Lustig K; Milting H; Kast R; Klein M
    Cardiovasc Res; 2009 Apr; 82(1):30-9. PubMed ID: 19131365
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Resveratrol reverses monocrotaline-induced pulmonary vascular and cardiac dysfunction: a potential role for atrogin-1 in smooth muscle.
    Paffett ML; Lucas SN; Campen MJ
    Vascul Pharmacol; 2012; 56(1-2):64-73. PubMed ID: 22146233
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Baicalein attenuates monocrotaline-induced pulmonary arterial hypertension by inhibiting vascular remodeling in rats.
    Shi R; Wei Z; Zhu D; Fu N; Wang C; Yin S; Liang Y; Xing J; Wang X; Wang Y
    Pulm Pharmacol Ther; 2018 Feb; 48():124-135. PubMed ID: 29133079
    [TBL] [Abstract][Full Text] [Related]  

  • 26. NTP42, a novel antagonist of the thromboxane receptor, attenuates experimentally induced pulmonary arterial hypertension.
    Mulvaney EP; Reid HM; Bialesova L; Bouchard A; Salvail D; Kinsella BT
    BMC Pulm Med; 2020 Apr; 20(1):85. PubMed ID: 32252727
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Jiedu Quyu Decoction mitigates monocrotaline-induced right-sided heart failure associated with pulmonary artery hypertension by inhibiting NLRP3 inflammasome in rats.
    Ma Q; Wang M; Li L; Zhang X; Cui L; Mou J; Sun G; Zhang Q
    J Ethnopharmacol; 2023 Sep; 313():116556. PubMed ID: 37142147
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tetrandrine prevents monocrotaline-induced pulmonary arterial hypertension in rats through regulation of the protein expression of inducible nitric oxide synthase and cyclic guanosine monophosphate-dependent protein kinase type 1.
    Wang X; Yang Y; Yang D; Tong G; Lv S; Lin X; Chen C; Dong W
    J Vasc Surg; 2016 Nov; 64(5):1468-1477. PubMed ID: 26527422
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combination therapy with fasudil and sildenafil ameliorates monocrotaline-induced pulmonary hypertension and survival in rats.
    Elias-Al-Mamun M; Satoh K; Tanaka S; Shimizu T; Nergui S; Miyata S; Fukumoto Y; Shimokawa H
    Circ J; 2014; 78(4):967-76. PubMed ID: 24553194
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of preventive effect of sildenafil and therapeutic effect of sildenafil treatment in rats with monocrotaline-induced pulmonary arterial hypertension.
    Yoshiyuki R; Fukushima R; Tanaka R; Machida N
    J Vet Med Sci; 2016 Nov; 78(10):1607-1610. PubMed ID: 27320637
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Betaine Attenuates Monocrotaline-Induced Pulmonary Arterial Hypertension in Rats via Inhibiting Inflammatory Response.
    Yang JM; Zhou R; Zhang M; Tan HR; Yu JQ
    Molecules; 2018 May; 23(6):. PubMed ID: 29861433
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sildenafil improves right ventricular remodelling in monocrotaline-induced rats by decreasing myocardial apoptosis and activating peroxisome proliferator-activated receptors.
    Li YL; Li YQ; Zeng FQ; Lin XY; Li XT; Ren XQ; Yang DL
    J Pharm Pharmacol; 2021 Mar; 73(2):145-151. PubMed ID: 33793805
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prolonged inhaled NO attenuates hypoxic, but not monocrotaline-induced, pulmonary vascular remodeling in rats.
    Horstman DJ; Frank DU; Rich GF
    Anesth Analg; 1998 Jan; 86(1):74-81. PubMed ID: 9428855
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alginate Oligosaccharide Alleviates Monocrotaline-Induced Pulmonary Hypertension via Anti-Oxidant and Anti-Inflammation Pathways in Rats.
    Feng W; Hu Y; An N; Feng Z; Liu J; Mou J; Hu T; Guan H; Zhang D; Mao Y
    Int Heart J; 2020 Jan; 61(1):160-168. PubMed ID: 31956132
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improved pulmonary vascular reactivity and decreased hypertrophic remodeling during nonhypercapnic acidosis in experimental pulmonary hypertension.
    Christou H; Reslan OM; Mam V; Tanbe AF; Vitali SH; Touma M; Arons E; Mitsialis SA; Kourembanas S; Khalil RA
    Am J Physiol Lung Cell Mol Physiol; 2012 May; 302(9):L875-90. PubMed ID: 22287610
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activation of Nicotinic Acetylcholine α7 Receptor Attenuates Progression of Monocrotaline-Induced Pulmonary Hypertension in Rats by Downregulating the NLRP3 Inflammasome.
    Deng Y; Guo SL; Wei B; Gao XC; Zhou YC; Li JQ
    Front Pharmacol; 2019; 10():128. PubMed ID: 30863307
    [No Abstract]   [Full Text] [Related]  

  • 37. Glycyrrhizin, inhibitor of high mobility group box-1, attenuates monocrotaline-induced pulmonary hypertension and vascular remodeling in rats.
    Yang PS; Kim DH; Lee YJ; Lee SE; Kang WJ; Chang HJ; Shin JS
    Respir Res; 2014 Nov; 15():148. PubMed ID: 25420924
    [TBL] [Abstract][Full Text] [Related]  

  • 38. S-Nitroso-L-Cysteine Ameliorated Pulmonary Hypertension in the MCT-Induced Rats through Anti-ROS and Anti-Inflammatory Pathways.
    Wang M; Luo P; Shi W; Guo J; Huo S; Yan D; Peng L; Zhang C; Lv J; Lin L; Li S
    Oxid Med Cell Longev; 2021; 2021():6621232. PubMed ID: 33574976
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 3-Hydroxy-3-methylglutaryl (HMG)-COA reductase inhibitors and phosphodiesterase type V inhibitors attenuate right ventricular pressure and remodeling in a rat model of pulmonary hypertension.
    Satoh M; Satoh A
    J Pharm Pharm Sci; 2009 Feb; 11(2):118s-130s. PubMed ID: 19203474
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 2-Methoxyestradiol mediates the protective effects of estradiol in monocrotaline-induced pulmonary hypertension.
    Tofovic SP; Zhang X; Jackson EK; Dacic S; Petrusevska G
    Vascul Pharmacol; 2006 Dec; 45(6):358-67. PubMed ID: 16872912
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.